Use of Wii Home Computer in Patients With Chronic Obstructive Pulmonary Disease: Effects on Quality of Life

NCT01539421 | Completed

• 1 other identifier: 10-06-007
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

This study was designed to evaluate the effectiveness of 12 weeks' home exercise training using the Nintendo ® Wii Fit system in patients with COPD. Following an initial pilot study at one institution to determine the physiological responses to exercise training using the home based interactive computer system, a longitudinal study was performed to evaluate outcomes across several areas. Outcomes were measured at baseline, after 6 weeks of standard care, and after 6 and 12 weeks of home exercise training. Three hospital based pulmonary rehabilitation centers in Connecticut participated in the longitudinal study.

Conditions

COPD

Keywords

COPD; exercise endurance

Outcome Measures

Primary Outcomes (1)

• Oxygen Consumption (VO2) during Wii Exercise

  30 minutes per day

Secondary Outcomes (1)

• Gender Differences in ESWT performance

  12 weeks

Study Arms (1)

Exercise Intervention

EXPERIMENTAL

Use of Wii computer for enhanced exercise in COPD patients.

Behavioral: Use of Home exercise computer program

Interventions

Use of Home exercise computer program BEHAVIORAL

After a 30-minute rest period the study patient performed a series of 4 representative exercises from the Wii under direct supervision by an investigator. Five minutes' rest was allotted between each exercise. The patient was instructed to exercise at his/her own pace, with a maximal duration of 5 minutes per exercise. The Oxycon Mobile was worn throughout this exercise, and the metabolic measurements listed above were recorded over the last 30 seconds of each exercise. The exercises included running in place, upper arm movements, stepping in place, and obstacle course.

Exercise Intervention

Eligibility Criteria

• Age: 40 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Informed consent (Approval by the St. Francis Hospital IRB will be required before study initiation)
• Adults, age \> 40 years
• A clinical diagnosis of COPD, with spirometric confirmation: post-bronchodilator FEV1/FVC \< 0.70
• Moderate, severe and very severe airflow limitation by GOLD criteria.
• Clinically stable respiratory disease
• The perceived ability to participate in pulmonary testing and exercise testing
• COPD, stable state

You may not qualify if:

• Women of childbearing potential
• Asthma
• Supplemental oxygen use or anticipated oxygen desaturation \< 85% at peak exercise (patients who desaturate below 85% on the incremental study will be excluded)
• Co-morbidity that would interfere with the patient participating in the study, including the exercise testing. Examples include unstable cardiac disease, arthritis, psychological problems that would interfere with participation
• An exacerbation requiring therapy or any change in maintenance COPD therapy within six weeks of testing
• A history of a prolonged QT interval
• Recent exacerbation of COPD

Sponsors & Collaborators

• Trinity Health Of New England: lead
• Boehringer Ingelheim: collaborator

Study Sites (1)

St Francis Hospital and Medical center

Hartford, Connecticut, 06105, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Richard ZuWallack, MD

  Saint Francis Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 21, 2012
• First Posted: February 27, 2012
• Study Start: June 1, 2010
• Primary Completion: July 1, 2011
• Study Completion: October 1, 2011
• Last Updated: February 28, 2012

Record last verified: 2012-02

Locations

US (1)